申请人:Hoechst Aktiengesellschaft
公开号:US06020350A1
公开(公告)日:2000-02-01
There are described 3-hydrixypyridine-2-carboxamidoesters of the formula ##STR1## their preparation, their use for the inhibition of collagen biosynthesis and their use as pharmaceuticals for the treatment of fibrotic disorders.
本文描述了式子##STR1##的3-羟基吡啶-2-羧酰胺酯的制备方法,以及它们用于抑制胶原蛋白生物合成和作为治疗纤维化疾病的药物的用途。